@pipeworx/ca-drug-price-transparency
Connect: https://pipeworx.io/mcp — every tool in the catalog, including @pipeworx/ca-drug-price-transparency’s. Install: one-click buttons
Connect to just the @pipeworx/ca-drug-price-transparency pack
https://gateway.pipeworx.io/ca-drug-price-transparency/mcp — only @pipeworx/ca-drug-price-transparency’s own tools, nothing else in the catalog.
No MCP client? Skip the connection: POST https://gateway.pipeworx.io/v1/tools/search_packs {"query":"..."} to find a tool below, GET /v1/tools/<name> for its schema, POST the same URL with arguments for the data — see For AI agents.
Tools: 3
California manufacturer disclosures of prescription drug list-price (WAC) increases and new-drug launch prices — the reports drug makers are required to file under California’s Cost Transparency Rx (CTRx) law. Read live; keyless.
Tools
ca_rx_wac_increases(drug?, manufacturer?, ndc?, year?, limit?)— manufacturer disclosures of a WAC increase past the statutory threshold. Returns the increase amount, the WAC after increase, and the effective date.ca_rx_wac_five_year_history(ndc, year?, limit?)— the 5-year WAC history a manufacturer must disclose alongside each increase report for that NDC.ca_rx_new_drug_launches(drug?, manufacturer?, year?, limit?)— manufacturer disclosures of a NEW drug launched with a WAC above the Medicare Part D specialty-drug threshold, with estimated patient population and any breakthrough-therapy/priority-review designation.
All three default to searching every available report year (2019–present) when
year is omitted, and return a count + years_searched summary before any
records; a no-match response names the filters tried rather than an empty
array.
Auth
Keyless.
Data sources
- California Department of Health Care Access and Information (HCAI), Cost Transparency Rx (CTRx) program — manufacturer WAC increase reports, their 5-year increase histories, and new-drug introduction reports. Published as open datasets with one monthly (in-progress current year) and one closed annual file per year back to 2019.
Coverage — why this pack is California-only (fleet #3245 survey, 2026-10-18)
Several states run a manufacturer WAC/launch-price disclosure law similar to
California’s. Surveyed before building, because CLAUDE.md’s “one pack per
jurisdiction” rule means a second state with genuinely structured public data
gets its own pack, not a state argument here — the schemas and even the
reporting thresholds differ per state, and a multiplexed pack cannot describe
either honestly:
| State | Publishes a structured public dataset? | Status |
|---|---|---|
| California | Yes — open CKAN datasets, queryable, 2019–present | Built here |
| Minnesota | Yes — two fixed Excel snapshot files (price-growth, new-drug), no history API | Public, keyless, file-only; candidate for a separate local-copy pack, not built in this pass |
| Oregon | No — manufacturers submit through an account-gated portal (iReg); no public query/download tool was found | Not buildable without a credential |
| Colorado | No — Division of Insurance posts narrative PDF reports only | Not structured |
| Vermont | No — Green Mountain Care Board / AG publish narrative PDF reports only | Not structured |
| Nevada | No — DHHS publishes narrative PDF reports (diabetes/insulin-focused) only | Not structured |
| Washington | No — HCA/PDAB publish narrative PDF reports and a claims-based affordability dashboard, not manufacturer disclosure records | Not structured |
| Maine | No — MHDO publishes an annual narrative PDF report only | Not structured |
“Not structured” means no CSV/Excel/API was found publishing the underlying manufacturer-filed records — only a narrative PDF report summarizing them, which would require manual transcription rather than ingestion. Re-verify before assuming this is permanent: states have moved from PDF-only to a real dataset before (this is exactly what California’s own CTRx program did).
Traps
Two header shapes per dataset, and they are not cosmetic. HCAI’s
“in-progress current year” resource uses snake_case machine column names
(manufacturer_name, wac_effective_date, wac_increase_amount as a JSON
number). Every CLOSED annual archive (2019 through last full year) uses human
Title-Case column names with spaces (“Manufacturer Name”, “WAC Effective
Date”) and stringifies the same amounts — the 5-year-history resource further
prefixes them with ”$” and commas in BOTH shapes. Matching on one spelling
silently drops every year that doesn’t use it; every normalizer here reads
both.
CKAN’s q full-text parameter is not a substring filter on the field you
think you’re searching. Measured 2026-10-18: q=Pfizer against a 1,251-row
resource with zero rows naming Pfizer anywhere still returned total: 151 —
it ranks relevance across every text column, including long narrative fields
like “General Comments”, and is capped by that ranking rather than by an exact
match. A real hit outside the top-ranked slice could be silently missed. This
pack uses datastore_search_sql (also keyless, confirmed live) with an
explicit ILIKE on the exact column being searched instead.
Resource ids are resolved live, not hardcoded. The “current year” resource
becomes a dated archive every January, the same way CMS’s NADAC dataset id
rotates (see mcps/drug-prices), and HCAI’s own id for it is not guaranteed
stable across that rollover. resolveResources() reads CKAN’s package_show
and classifies every resource by its NAME; a hardcoded last-known-good map
(captured 2026-10-18) is the fallback only if that live lookup itself fails.
The 5-year-history dataset can contain overlapping entries for the same
NDC. Each filed WAC Increase Report re-states the preceding 5 years of
history as of its own effective date, so a drug that had two increases in the
same window produces two reports whose history windows overlap. That is a
property of what HCAI publishes, not a dedup bug — ca_rx_wac_five_year_history
returns every filed history row rather than silently collapsing them.
WAC is the manufacturer’s published list price, not what anyone actually
pays. For the retail acquisition cost or the Medicare Part B payment limit,
see mcps/drug-prices (nadac_price / asp_payment_limit) — this pack
answers “what did the manufacturer disclose”, not “what does a pharmacy or
Medicare pay”.
Tools
- ca_rx_wac_increases — California manufacturer disclosures of a prescription drug’s Wholesale Acquisition Cost (WAC — the published list price before rebates/discounts) going UP. Required by California law (SB 17/AB 265) wh
- ca_rx_wac_five_year_history — The 5-year WAC increase history California requires manufacturers to disclose alongside each WAC Increase Report — every prior increase for that NDC over the preceding 5 calendar years, with its date
- ca_rx_new_drug_launches — California manufacturer disclosures of a NEW prescription drug launched with a Wholesale Acquisition Cost (WAC — published list price) exceeding the Medicare Part D specialty-drug cost threshold — Cal
Tools
ca_rx_new_drug_launches— California manufacturer disclosures of a NEW prescription drug launched with a Wholesale Acquisition Cost (WAC — published list price) exceeding the Medicare Part D specialty-drug cost threshold — Calca_rx_wac_five_year_history— The 5-year WAC increase history California requires manufacturers to disclose alongside each WAC Increase Report — every prior increase for that NDC over the preceding 5 calendar years, with its dateca_rx_wac_increases— California manufacturer disclosures of a prescription drug's Wholesale Acquisition Cost (WAC — the published list price before rebates/discounts) going UP. Required by California law (SB 17/AB 265) wh